PD‐1‐specific “Blocking” antibodies that deplete PD‐1+ T cells present an inconvenient variable in preclinical immunotherapy experiments - Polesso - 2021 - European Journal of Immunology - Wiley Online Library
Anti-PD-L1 mIgG1e3 monoclonal antibody | Atezolizumab-based
Anti-PD-1 Antibody Therapy Potently Enhances the Eradication of Established Tumors By Gene-Modified T Cells | Clinical Cancer Research
Human PD-L1 Antibody (PDL1.D1), mAb, Mouse - GenScript
Mouse PD-L1 Antibody AF1019: R&D Systems
Anti-mouse PD-1 (CD279) Antibody | Recombinant RMP1-14 | InvivoGen
Anti-PD-1 Neutralizing Antibody
Anti-PD-1 Blocking Antibody Inhibits Murine Melanoma Growth in... | Download Scientific Diagram
TLR4 signaling improves PD-1 blockade therapy during chronic viral infection
Release the B7.1! Anti-PD-L1 breaks PD-L1's grip
Frontiers | PD-1/PD-L1 Based Combinational Cancer Therapy: Icing on the Cake | Pharmacology
Engineering high-affinity PD-1 variants for optimized immunotherapy and immuno-PET imaging | PNAS
Anti-Mouse CD279 Clone 29F.1A12 (PD-1) - In vivo Functional Grade
Anti-mouse PD-1 (CD279) Antibody | Recombinant RMP1-14 | InvivoGen
Human PD-1 Antibody (PD1.D3), mAb, Mouse - GenScript
Anti-PD-1 Blocking Antibody Inhibits Human Melanoma Xenograft Growth in... | Download Scientific Diagram
Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivo | Nature Biotechnology
The FG Loop of PD-1 Serves as a “Hotspot” for Therapeutic Monoclonal Antibodies in Tumor Immune Checkpoint Therapy - ScienceDirect
Bio X Cell - InVivoPlus anti-mouse PD-1 (CD279)
PD-1 (EH33) Mouse mAb (IHC-Specific) | Cell Signaling Technology
Collagen promotes anti-PD-1/PD-L1 resistance in cancer through LAIR1-dependent CD8+ T cell exhaustion | Nature Communications
Selective HDAC6 inhibitors improve anti-PD-1 immune checkpoint blockade therapy by decreasing the anti-inflammatory phenotype of macrophages and down-regulation of immunosuppressive proteins in tumor cells | Scientific Reports
